We are live on ! Find out more
NPPM

North Point Portfolio Managers Portfolio holdings

AUM $561M
1-Year Est. Return 15.77%
This Fund
S&P 500
This Quarter Est. Return
+4.9%
1 Year Est. Return
+15.77%
3 Year Est. Return
+55%
5 Year Est. Return
+69.33%
10 Year Est. Return
+287.56%
AUM
$556M
AUM Growth
+$26.2M
Cap. Flow
+$4.79M
Cap. Flow %
0.86%
Top 10 Hldgs %
33.09%
Holding
87
New
4
Increased
19
Reduced
26
Closed
3

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$10.8M
2
AGN
Allergan plc
AGN
+$494K
3
BLK icon
Blackrock
BLK
+$421K
4
GS icon
Goldman Sachs
GS
+$281K
5
COST icon
Costco
COST
+$244K

Top Sells

Rank Stock Value
1
VAL
Valspar
VAL
+$4.7M
2
THO icon
Thor Industries
THO
+$387K
3
PEP icon
PepsiCo
PEP
+$360K
4
TFC icon
Truist Financial
TFC
+$347K
5
ANSS
Ansys
ANSS
+$327K

Sector Composition

Rank Sector Weight
1 Technology 26.8%
2 Healthcare 19.42%
3 Financials 15.35%
4 Consumer Discretionary 13.75%
5 Consumer Staples 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COST icon
26
Costco
COST
$415B
$12.3M 2.21%
73,340
+1,457
+2% +$244K
XOM icon
27
ExxonMobil
XOM
$651B
$12M 2.16%
146,508
-312
-0.2% -$26.1K
HAL icon
28
Halliburton
HAL
$27.9B
$11.7M 2.11%
237,761
+3,734
+2% +$201K
REGN icon
29
Regeneron Pharmaceuticals
REGN
$68.8B
$11.3M 2.04%
+29,244
New +$10.8M
ABT icon
30
Abbott
ABT
$180B
$11.2M 2.01%
251,806
-6,225
-2% -$269K
DOV icon
31
Dover
DOV
$27.2B
$11.1M 2%
171,404
-1,844
-1% -$118K
AGN
32
DELISTED
Allergan plc
AGN
$10.8M 1.94%
45,117
+2,123
+5% +$494K
GGG icon
33
Graco
GGG
$12.9B
$10.6M 1.91%
338,721
-5,358
-2% -$162K
FTV icon
34
Fortive
FTV
$19B
$10.6M 1.9%
278,494
+1,605
+0.6% +$57.6K
PG icon
35
Procter & Gamble
PG
$343B
$9.28M 1.67%
103,229
+321
+0.3% +$28.5K
AYI icon
36
Acuity Brands
AYI
$9.88B
$9.13M 1.64%
44,771
+767
+2% +$162K
APA icon
37
APA Corp
APA
$12.8B
$8.04M 1.45%
156,471
+1,211
+0.8% +$68.1K
AAN.A
38
DELISTED
The Aaron's Company Inc Class A
AAN.A
$7.92M 1.43%
266,254
+4,870
+2% +$145K
ENOV icon
39
Enovis
ENOV
$1.56B
$7.83M 1.41%
115,952
-2,054
-2% -$137K
CF icon
40
CF Industries
CF
$19.2B
$5.28M 0.95%
180,035
-2,895
-2% -$94.4K
LLY icon
41
Eli Lilly
LLY
$1.07T
$406K 0.07%
4,825
– –
XEL icon
42
Xcel Energy
XEL
$51B
$374K 0.07%
8,407
– –
LNC icon
43
Lincoln National
LNC
$7.91B
$371K 0.07%
5,675
– –
QQQ icon
44
Invesco QQQ Trust
QQQ
$455B
$364K 0.07%
2,750
– –
JNJ icon
45
Johnson & Johnson
JNJ
$635B
$362K 0.07%
2,903
– –
MSFT icon
46
Microsoft
MSFT
$2.84T
$352K 0.06%
5,350
– –
CWT icon
47
California Water Service
CWT
$3.04B
$330K 0.06%
9,208
– –
VVC
48
DELISTED
Vectren Corporation
VVC
$325K 0.06%
5,550
– –
CVX icon
49
Chevron
CVX
$388B
$319K 0.06%
2,975
+100
+3% +$11.2K
GE icon
50
GE Aerospace
GE
$367B
$311K 0.06%
2,177
-45
-2% -$6.51K
1
2
3 4

Similar funds

MCM
Maytus Capital Management New York $562M AUM 71.97% 1-Year Est. Return
FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM
AC
Addison Capital Conshohocken, Pennsylvania $562M AUM 18.57% 1-Year Est. Return
PDL
Portfolio Design Labs Encino, California $562M AUM 20.39% 1-Year Est. Return
MP
Moment Partners San Francisco, California $561M AUM 16.01% 1-Year Est. Return
GWAG
Garrett Wealth Advisory Group Weatherford, Texas $562M AUM 16.6% 1-Year Est. Return
AMCA
Arthur M. Cohen & Associates Northbrook, Illinois $563M AUM 20.97% 1-Year Est. Return
OPWM
Oakwell Private Wealth Management Austin, Texas $560M AUM 20.18% 1-Year Est. Return

North Point Portfolio Managers's Q1 2017 Portfolio in Review

As of Q1 2017, North Point Portfolio Managers held 87 positions worth $556M, up 5% from $529M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

North Point Portfolio Managers's Q1 2017 filing shows 4 new, 19 increased, 26 reduced and 3 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 29,244 shares worth $11.3M. The largest sale was Valspar, an estimated $4.7M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • North Point Portfolio Managers's largest Q1 2017 buy was Regeneron Pharmaceuticals: 29,244 shares worth $11.3M.
  • North Point Portfolio Managers added most to Allergan plc in Q1 2017, an estimated $494K increase.
  • North Point Portfolio Managers's biggest Q1 2017 reduction was Thor Industries, cutting an estimated $387K.
  • North Point Portfolio Managers fully exited Valspar in Q1 2017, selling an estimated $4.7M.
  • North Point Portfolio Managers's ten largest holdings make up 33% of its $556M portfolio in Q1 2017.
  • North Point Portfolio Managers opened 4 new positions and closed 3 in Q1 2017.
  • North Point Portfolio Managers's portfolio value rose 5% quarter-over-quarter to $556M.

Based on North Point Portfolio Managers's 13F filing for Q1 2017, filed 25 Apr 2017.